LIVE MARKETS-S&P 500 futures red after hot CPI data pushes yields higher
Reuters2026/10/14 13:09Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at [email protected]
S&P 500 FUTURES RED AFTER HOT CPI DATA PUSHES YIELDS HIGHER
US stock futures moved into the red Wednesday morning after a mostly hotter-than-expected inflation report led investors to raise their expectations for future Federal Reserve tightening.
E-mini S&P 500 futures Esc1 were recently down about 0.3%, reversing from a gain of roughly 0.3% before the consumer price index (CPI) data was released.
The September inflation report was generally firmer than expected. Headline CPI rose 0.6% month-over-month, matching forecasts, while annual inflation came in at 3.7%, slightly above the 3.6% consensus estimate. Core CPI, which excludes food and energy, increased 0.3% on the month versus expectations for 0.2%, while the year-over-year core reading was 2.6%, above the 2.5% forecast.
The data prompted traders to reassess the outlook for Fed policy. According to CME's FedWatch tool, the odds that the Fed leaves rates unchanged at its October 27-28 meeting fell to 56% from 78% before the report. Meanwhile, the probability of a 25-basis-point rate hike climbed to about 44% from 22%.
Rate expectations further out the curve also shifted higher. Fed funds futures now imply the policy rate will be about 37.1 basis points higher by December 2026, up from 26.9 basis points before the inflation numbers were released.
Treasury yields jumped in response. The benchmark 10-year Treasury yield US10YT=RR rose to around 5.33%, up from roughly 5.19% immediately before the data and above Tuesday's close of 5.217%.
The rise in yields is weighing on most sectors in premarket trading. Among the S&P 500 .SPX sector ETFs, technology XLK.P is the biggest laggard, down about 1%, while energy XLE.P is bucking the trend and gaining roughly 0.8%.
Other rate-sensitive areas are also under pressure. The Invesco KBW Bank ETF KBWB.O is down around 1.9%, while the Invesco PHLX Semiconductor ETF SOXQ.O is off about 2%.
Regarding the data, Sam Stovall, chief investment strategist at CFRA Research in New York, said:
"It certainly does increase the odds of the Fed raising rates at the October meeting but I still believe that they're not going to raise rates because we have never had two rate hikes within two months of midterm election years."
Stovall added, "I would tend to say that because inflation does not appear as if it's running away and the Fed has already indicated that it is going to take a more of a hawkish approach to inflation. It certainly increases the likelihood of a rate hike in December."
Here is a premarket snapshot from around 8:53 a.m. ET.
(Terence Gabriel, Tharuniyaa Lakshmi)
*****
EARLIER ON LIVE MARKETS:
EURO/YEN SHORTS ON JAPAN INVESTOR OAT SALES OVERDONE, SAYS UBS CLICK HERE
WHAT IF REPUBLICANS LOSE BOTH CHAMBERS CLICK HERE
RBC ROTATES INTO HEALTHCARE, TRIMS US TECH EXPOSURE CLICK HERE
WHO’S BETTING ON AN EARNINGS BOOST FOR US STOCKS CLICK HERE
STOXX GAINS, MORGAN STANLEY TALKS UP EARNINGS CLICK HERE
BEFORE THE BELL: EUROPE EYES FIRMER START, TECH LOOKS SHAKY CLICK HERE
LET THE DOVES SING CLICK HERE
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cyclical stocks always peak when they're “cheapest” — Citrini, the “chip influencer” who was the earliest to be bullish on AI hardware, is now quietly exiting
Citrini, once the most prominent bull in AI hardware, has now significantly reduced his semiconductor holdings and currently holds some short positions. He believes that the financing structure for AI infrastructure has shifted from tech giants' own cash flows to equity and debt markets, and that sentiment alone could sever the funding chain and impact fundamentals. Strategically, he is long Meta and short Google. Citrini also asserts that the bottleneck in AI pharmaceutical development is not computational power, but rather a "lack of monkeys."
New Zealand Dollar gains ground to near 0.5700 as RBNZ rate hike bets rise
Median survival prolonged by 5.7 months! Roche (RHHBY.US) lung cancer new drug wins in head-to-head trial, major catalyst for oncology business
Roche's investigational lung cancer drug divarasib extended patient survival by nearly six months compared to competing therapies in a late-stage clinical trial, promising to further strengthen the Swiss pharmaceutical company's oncology portfolio.
Global Aging Reshapes Equity and Bond Investment Logic? Pension "Longevity Bill" Accelerates Accumulation, Equities, Bonds, and Private Equity Welcome Massive Long-term Capital
As people live longer and birth rates decline, pension funds are required to allocate their assets for retirement periods that can last decades. Meanwhile, the number of workers contributing to these systems is decreasing.
Crypto prices
More
